http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556162-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 |
filingDate | 2014-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6534575548e2f355d4935dd768aa98e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ccbfcca4a25073c1eb317885acee8b4 |
publicationDate | 2017-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-9556162-B2 |
titleOfInvention | Compound for the treatment of hepatitis C |
abstract | The present invention provides (R)-5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamoyl)phenyl)-6-(sec-butyl)-2-(4-fluorophenyl)-N-methylbenzofuran-3-carboxamide (formula I), including pharmaceutically acceptable salts, as well as compositions and methods of using the compound. The compound has activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. |
priorityDate | 2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 503.